Immune Anti-Inhibitor Market, by Product Type (Recombinant, Plasma-Derived, and Others), by Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies), by Geography - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026
Immune inhibitors are associated with haemophilia and inhibitors are antibodies developed in haemophilia patients. Haemophilia is a hereditary bleeding disorder, which occurs due to deficiency or absence of clotting factor VIII (haemophilia A) or clotting factor IX (haemophilia B). Although classification is not limited to the type of deficient clotting factor, it can be classified according to amount of clotting factor present as well. For instance, depending on factor VIII levels in patients with haemophilia A, it can be classified as mild haemophilia (5-25% of normal values), moderate haemophilia (1-5% of normal values), and severe haemophilia (